New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 180mg - capsule - 180 mg - active: temozolomide 180mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 20mg - capsule - 20 mg - active: temozolomide 20mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 250mg - capsule - 250 mg - active: temozolomide 250mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 5mg - capsule - 5 mg - active: temozolomide 5mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint green sb-4020 titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - triclosan, quantity: 10 mg/ml - application - excipient ingredients: edetate sodium; methyl hydroxybenzoate; dibasic sodium phosphate; purified water; citric acid; ethanol; sodium lauryl sulfate; fragrance (perfume); glycerol; cocamide dea; coconut oil; diethanolamine - a foaming emolient antiseptic soap for pre-operative washing to cleanse and disinfect the skin.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - ranitidine hydrochloride -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - hexachlorophene, quantity: 30 mg/g - lotion - excipient ingredients: sodium lauryl sulfate; citric acid; methyl hydroxybenzoate; ethanol; purified water; dibasic sodium phosphate heptahydrate; fragrance (perfume); glycerol; cocamide dea; coconut oil; diethanolamine - disinfection of skin.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - diazepam -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - sorbitol solution (70 per cent) (non-crystallising) -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - chloral hydrate, quantity: 50 mg/ml - oral liquid, solution - excipient ingredients: glycerol; sucrose; anise oil; ethanol; methyl hydroxybenzoate; saccharin sodium; citric acid; purified water; flavour - indications as at 19 september 2003: chloral hydrate mixture is indicated pre-operatively to produce sedation. it is also indicated for short term (not more than 2 weeks) use as a hypnotic to assist in sleep disorders.